Back to Search
Start Over
United States : Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease
- Source :
- Mena Report. December 20, 2016
- Publication Year :
- 2016
-
Abstract
- Ionis Pharmaceuticals, Inc. announced today that it has advanced its lead drug candidate IONIS-AZ4-2.5-LRx, which has now been renamed AZD8233, into preclinical development. AZD8233 is designed to inhibit an undisclosed [...]
Details
- Language :
- English
- ISSN :
- 22190112
- Database :
- Gale General OneFile
- Journal :
- Mena Report
- Publication Type :
- News
- Accession number :
- edsgcl.475784198